KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Prepaid Assets (2016 - 2026)

TherapeuticsMD filings provide 17 years of Prepaid Assets readings, the most recent being $415000.0 for Q1 2026.

  • On a quarterly basis, Prepaid Assets rose 79.65% to $415000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $415000.0, a 79.65% increase, with the full-year FY2025 number at $89000.0, down 87.19% from a year prior.
  • Prepaid Assets hit $415000.0 in Q1 2026 for TherapeuticsMD, up from $89000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $5.4 million in Q1 2023 to a low of $89000.0 in Q4 2025.
  • Median Prepaid Assets over the past 5 years was $1.4 million (2023), compared with a mean of $2.1 million.
  • Biggest five-year swings in Prepaid Assets: skyrocketed 803.76% in 2023 and later tumbled 95.76% in 2024.
  • TherapeuticsMD's Prepaid Assets stood at $1.2 million in 2022, then rose by 24.08% to $1.4 million in 2023, then tumbled by 52.0% to $695000.0 in 2024, then crashed by 87.19% to $89000.0 in 2025, then surged by 366.29% to $415000.0 in 2026.
  • The last three reported values for Prepaid Assets were $415000.0 (Q1 2026), $89000.0 (Q4 2025), and $3.7 million (Q3 2025) per Business Quant data.